Concepedia

Paul E. Gormley

PE

Statistics

Publications

12

Citations

539

H-Index

11

Active since

1978

Affiliations

National Institutes of Health(Current)

National Cancer Institute

University of Pennsylvania

Paul E. Gormley is an author at National Institutes of Health specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1978–2008

12

Publications

12

Kinetics of <i>cis</i>‐dichlorodiammineplatinum

Paul E. Gormley, Joan M. Bull, A Leroy et al. · Clinical Pharmacology & Therapeutics · 1979 · 191 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.

Robert C. Young, Daniel D. Von Hoff, Paul E. Gormley et al. · PubMed · 1980 · 73 citations

Medicine, Oncology, Pharmacology +15

Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.

Paul E. Gormley, V.Sagar Sethi, Richard L. Cysyk · PubMed · 1978 · 44 citations

Life Sciences, Biochemistry, Molecular Biology +17

Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.

Von Hoff, K Howser, Paul E. Gormley et al. · PubMed · 1978 · 42 citations

Medicine, Oncology, Pharmacology +14

Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.

David A. Van Echo, Delia F. Chiuten, Paul E. Gormley et al. · PubMed · 1979 · 38 citations

Medicine, Pharmacokinetics, Pharmacology +14

1–5 of 12